Study of Paclitaxel Micelles for Injection in Chinese Patients With Advanced Solid Tumors.

This study tests a new formulation of paclitaxel (a standard chemotherapy drug) called "paclitaxel micelles" — tiny nanoparticles that may deliver the drug more effectively and with fewer side effects — in Chinese patients with advanced solid tumors that have not responded to standard treatments. **You may be eligible if...** - You are 18–70 years old with a confirmed advanced solid tumor - Standard cancer treatments are no longer working or available for you - Your life expectancy is at least 3 months - You are in reasonably good health (ECOG 0–2) - You have at least one measurable or evaluable tumor on imaging **You may NOT be eligible if...** - You have received chemotherapy, radiation, or other cancer treatments within the past 4 weeks - You have brain metastases (cancer that has spread to the brain) - You have significant heart, liver, or kidney problems - You are pregnant or breastfeeding Talk to your doctor to see if this trial is right for you.